Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis. - Torkildsen Ø; Brustad HK; Høgestøl EA; Alstadhaug KB; Bhan A; Flemmen HØ; Habbestad A; Høglund RAA; LeBlanc M; Lopen P; Lorentzen ÅR; Morsund ÅH; et al. (The New England journal of medicine, 2026)